Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram

Joint · GILEAD SCIENCES, INC. · Gilead Sciences Inc Option Type: Put Strike price: $70.00 Expires: 11/15/2024
Purchase
Disclosed range starting at $1K
Disclosed 817 days after execution (STOCK Act deadline: 45)
Reverses direction: 1 prior trade the other way
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 24 | Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp | Open-market sale · 10b5-1 plan | SELL | $558K 3,399 sh | Nov 9, 2026 traded Nov 6, 2026 | |
| 0 | O'Day Daniel PatrickDirector, Chairman & CEO | Option exercise · 10b5-1 plan | M | — 9,810 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 7 | O'Day Daniel PatrickDirector, Chairman & CEO | Option exercise · 10b5-1 plan | M | — 102.6K sh | Nov 6, 2026 traded Nov 4, 2026 | |
| 15 | O'Day Daniel PatrickDirector, Chairman & CEO | Open-market sale · 10b5-1 plan | SELL | $1.72M 9,810 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 8 | O'Day Daniel PatrickDirector, Chairman & CEO | Option exercise · 10b5-1 plan | M | $7.42M 102.6K sh | Nov 6, 2026 traded Nov 4, 2026 | |
| 22 | O'Day Daniel PatrickDirector, Chairman & CEO | Open-market sale · 10b5-1 plan | SELL | $17.98M 102.6K sh | Nov 6, 2026 traded Nov 4, 2026 | |
| 1 | O'Day Daniel PatrickDirector, Chairman & CEO | Option exercise · 10b5-1 plan | M | $710K 9,810 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 7 | Mercier JohannaChief Comm & Corp Aff Officer | Open-market sale · 10b5-1 plan | SELL | $469K 3,000 sh | Oct 16, 2026 traded Oct 15, 2026 | |
| 24 | Burkhart ErinSVP, Controllership | Tax withholding | F | $117K 768 sh | Sep 23, 2026 traded Sep 22, 2026 | |
| 17 | Burkhart ErinSVP, Controllership | Option exercise | M | — 2,223 sh | Sep 23, 2026 traded Sep 22, 2026 | |
| 9 | Burkhart ErinSVP, Controllership | Option exercise | M | — 2,223 sh | Sep 23, 2026 traded Sep 22, 2026 | |
| 5 | Mercier JohannaChief Comm & Corp Aff Officer | Option exercise | M | — 2,797 sh | Sep 11, 2026 traded Sep 10, 2026 | |
| 8 | Mercier JohannaChief Comm & Corp Aff Officer | Tax withholding | F | $195K 1,347 sh | Sep 11, 2026 traded Sep 10, 2026 | |
| 9 | O'Day Daniel PatrickDirector, Chairman & CEO | Option exercise | M | — 8,780 sh | Sep 11, 2026 traded Sep 10, 2026 | |
| 9 | Berger DietmarChief Medical Officer | Tax withholding | F | $38K 263 sh | Sep 11, 2026 traded Sep 10, 2026 | |
| 9 | Mercier JohannaChief Comm & Corp Aff Officer | Option exercise | M | — 2,797 sh | Sep 11, 2026 traded Sep 10, 2026 | |
| 9 | Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp | Option exercise | M | — 590 sh | Sep 11, 2026 traded Sep 10, 2026 | |
| 11 | O'Day Daniel PatrickDirector, Chairman & CEO | Tax withholding | F | $613K 4,230 sh | Sep 11, 2026 traded Sep 10, 2026 | |
| 13 | Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp | Option exercise | M | — 590 sh | Sep 11, 2026 traded Sep 10, 2026 | |
| 9 | Berger DietmarChief Medical Officer | Option exercise | M | — 533 sh | Sep 11, 2026 traded Sep 10, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.
= $8,001
Tommy Tuberville reported a purchase of Gilead Sciences Inc Option Type: Put Strike price: $70.00 Expires: 11/15/2024 (owner: joint). Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.